SCHEMBL20052041

SCHEMBL20052041

CON(C)C(=O)C1CN(B(C)O)CCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20052042 0.76 ATM (0.31) —
SCHEMBL415332 0.76 — —
SCHEMBL13391543 0.74 — —
SCHEMBL31029454 0.74 — —
SCHEMBL19798957 0.73 BCHE (0.35) —
SCHEMBL17464288 0.72 — —
SCHEMBL12879227 0.72 MAPT (0.30) —
SCHEMBL13876916 0.71 CYP3A4 (0.38) —
SCHEMBL14026513 0.71 CYP3A4 (0.38) —
SCHEMBL14366860 0.70 CPT2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9944658-B2 Beta-lactamase inhibitors VenatoRx Pharmaceuticals, Inc. (US) 2018-04-17 — — US disclosed
Send feedback